Patents by Inventor Kelly-Ann Sheppard

Kelly-Ann Sheppard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20180194846
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 12, 2018
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20180134791
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: July 23, 2015
    Publication date: May 17, 2018
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20160031993
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: July 23, 2015
    Publication date: February 4, 2016
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20130344091
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: August 29, 2013
    Publication date: December 26, 2013
    Applicant: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • Compositions and methods for increasing muscle growth
    Patent number: 8551482
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: October 8, 2013
    Assignee: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • Compositions and methods for increasing muscle growth
    Patent number: 8388968
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: March 5, 2013
    Assignee: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stefanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20120237521
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: May 31, 2012
    Publication date: September 20, 2012
    Applicant: NOVARTIS AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stefanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20100272734
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 28, 2010
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle TRIFILIEFF, Stefanie Urlinger
  • Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders
    Publication number: 20100003256
    Abstract: The present invention relates to the use of TGF-? antagonists for the treatment, amelioration, and diagnosis of parathyroid-related disorders, e.g., HPT-JT, familial isolated primary hyperparathyroidism (FIPH), and hyperparathyroidism-jaw tumor (HPT-JT) syndrome, as well as its attendant complications. The present invention also relates to the use of modulators of HRPT2 and its related PAF1 complex for the treatment, amelioration, and diagnosis of TGF?-related disorders, e.g., pulmonary hypertension, cancer, hypertension, fibrosis, wound healing. Assays of the identification of modulators of HRPT2/PAF1 and SMAD/TGF? are also provided.
    Type: Application
    Filed: June 5, 2007
    Publication date: January 7, 2010
    Applicant: NOVARTIS AG
    Inventors: Chris Lu, Kelly-Ann Sheppard, Jeffrey Porter, Andreas Bauer